SEC 13F Intelligence

Wespac Advisors, LLC / ABBV

Wespac Advisors, LLC’s Abbvie Inc Position

Does Wespac Advisors, LLC own Abbvie Inc (ABBV)? Not currently — the last reported position was 12.7K shares worth $2M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q3 2023
Shares
12.7K
% of Portfolio
+1.42%
Quarters Held
15
position exited

Position History ABBV

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q2 ’19: $2MQ3 ’19: $1MQ3 ’19Q4 ’19: $1MQ4 ’20: $2MQ4 ’20Q1 ’21: $1MQ2 ’21: $696,000Q2 ’21Q3 ’21: $2MQ4 ’21: $2MQ4 ’21Q1 ’22: $2MQ2 ’22: $3MQ2 ’22Q3 ’22: $2MQ1 ’23: $2MQ1 ’23Q2 ’23: $2MQ3 ’23: $2MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202312.7K$2M+1.42%
Q2 202312.1K$2M+1.31%
Q1 202312.7K$2M+1.91%
Q3 202211.7K$2M+2.12%
Q2 202217.1K$3M+1.99%
Q1 20229.4K$2M+1.64%
Q4 202114.6K$2M+1.32%
Q3 202114.4K$2M+0.96%
Q2 20216.2K$696,000+1.33%
Q1 202113.3K$1M+1.08%
Q4 202017.2K$2M+1.42%
Q4 201915.6K$1M+1.35%
Q3 201917.4K$1M+1.31%
Q2 201927.9K$2M+1.51%
Q4 201832.2K$3M+2.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wespac Advisors, LLC’s full portfolio or all institutional holders of ABBV.